GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Days Sales Outstanding

Intelgenx Technologies (FRA:0IL) Days Sales Outstanding : 324.79 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Days Sales Outstanding?

Intelgenx Technologies's average Accounts Receivable for the three months ended in Mar. 2024 was €0.57 Mil. Intelgenx Technologies's Revenue for the three months ended in Mar. 2024 was €0.16 Mil. Hence, Intelgenx Technologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 324.79.

The historical rank and industry rank for Intelgenx Technologies's Days Sales Outstanding or its related term are showing as below:

FRA:0IL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 58.56   Med: 99.66   Max: 294.16
Current: 217.68

During the past 13 years, Intelgenx Technologies's highest Days Sales Outstanding was 294.16. The lowest was 58.56. And the median was 99.66.

FRA:0IL's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 72.61 vs FRA:0IL: 217.68

Intelgenx Technologies's Days Sales Outstanding declined from Mar. 2023 (368.63) to Mar. 2024 (324.79).


Intelgenx Technologies Days Sales Outstanding Historical Data

The historical data trend for Intelgenx Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Days Sales Outstanding Chart

Intelgenx Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 289.32 80.10 109.66 258.59 237.27

Intelgenx Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 368.63 443.27 185.56 132.79 324.79

Competitive Comparison of Intelgenx Technologies's Days Sales Outstanding

For the Biotechnology subindustry, Intelgenx Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intelgenx Technologies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intelgenx Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Intelgenx Technologies's Days Sales Outstanding falls into.



Intelgenx Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Intelgenx Technologies's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0.669 + 0.57) / 2 ) / 0.953*365
=0.6195 / 0.953*365
=237.27

Intelgenx Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (0.57 + 0.569) / 2 ) / 0.16*365 / 4
=0.5695 / 0.16*365 / 4
=324.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intelgenx Technologies  (FRA:0IL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Intelgenx Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelgenx Technologies Business Description

Traded in Other Exchanges
N/A
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. The company focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer, and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and the United States. The company generates the majority of its revenue from Europe.

Intelgenx Technologies Headlines

No Headlines